Emmessar Biotech & Nutrition Ltd — Important, 13-11-2025: Company Update

EMMESSAR BIOTECH & NUTRITION LIMITED has announced that its board of directors reviewed and approved the financial results for the quarter and half-year ended September 30, 2025. For the quarter, total income from operations was Rs 185.03 Crore, yielding a net profit of Rs 12.39 Crore. The half-year saw total income at Rs 355.20 Crore, with a net profit of Rs 22.01 Crore. The company primarily operates in the Healthcare segment, supplemented by rent from leasehold land. Statutory Auditors provided an unqualified opinion on the results, and no investor complaints were received for the quarter, highlighting operational stability for shareholders.